Mohammad I Saleh (Mohammad Saleh)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Clinical and experimental pharmacology & physiology

Therapeutics and clinical risk management

British journal of clinical pharmacology

Journal of chemotherapy (Florence, Italy)

The University of Jordan

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Jordan Feb 07 2012

Jordan

Associate professor :: Biopharmaceuttics and Clinical Pharmacy

Publications

Hiba Al Fahmawi, Abla Albsoul-Younes, Mohammad I Saleh, Mahmoud Abu Abeeleh, Violet Kasabri
Drug Therapy Problems Identified by Clinical Pharmacists at a General Surgery Ward of an Academic Referral Hospital in Jordan. Therapeutics and clinical risk management 20 (2024)
Mariam Hantash Abdel Jalil, Noura Abdullah, Mervat M Alsous, Mohammad I Saleh, Khawla Abu Hammour
A systematic review of population pharmacokinetic analyses of digoxin in the paediatric population. British journal of clinical pharmacology 86 (7) (2020)
Osama Y Alshogran, Leen S Magarbeh, Karem H Alzoubi, Mohammad I Saleh, Omar F Khabour
Evaluation of the impact of waterpipe tobacco smoke exposure on the activity and expression of rat hepatic CYP450: a pharmacokinetic study. Inhalation toxicology 30 (13-14) (2019)
Mohammad I Saleh, Suhad Bani Melhim
A time-to-event analysis describing virologic response in patients with chronic hepatitis C infection. Journal of chemotherapy (Florence, Italy) 31 (5) (2019)
Mohammad I Saleh, Suhad Bani Melhim, Hanguin M Al-Ramadhani, Sameh Alzubiedi
Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients. European journal of drug metabolism and pharmacokinetics 44 (1) (2019)
Mohammad I Saleh
A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients. Clinical pharmacokinetics 56 (11) (2018)
Mohammad I Saleh, Nagham N Hindi
A population pharmacodynamic model characterizing neutropenia associated with pegylated interferon alpha 2-a therapy in patients with chronic hepatitis C viral infection. Naunyn-Schmiedeberg's archives of pharmacology 391 (9) (2018)
Nagham N Hindi, Mohammad I Saleh
Patient characteristics associated with peglyated interferon alfa-2a induced neutropenia in chronic hepatitis C patients. Clinical and experimental pharmacology & physiology 45 (7) (2018)
Bashar A Alkhalidi, Mohammad I Saleh, Saja Hamed, Yasser K Bustanji, Nader R Albujuq, Naji Najib, Susana Torrado-Susana, Al-Sayed Sallam
Clarithromycin laurate salt: physicochemical properties and pharmacokinetics after oral administration in humans. Pharmaceutical development and technology 24 (5) (2018)
Mohammad I Saleh, Abdullah R Obeidat, Hanan A Anter, Anas A Khanfar
Eltrombopag dose predictors in thrombocytopenic subjects with hepatitis C virus infection. Clinical and experimental pharmacology & physiology 42 (10) (2016)

Mohammad I Saleh.css-eqlu8i{font-size:small;padding-left:4px;} (Mohammad Saleh)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammad I Saleh (Mohammad Saleh)